Both in Pharmaceuticals
CNS Pharmaceuticals vs Alzamend Neuro
Over the past year CNSP returned −34.2% and ALZN returned −39.0%; their daily moves had a correlation of 0.09.
CNSP −34.2% ALZN −39.0%Growth of $1, one year, split-adjusted
| Metric | CNSP | ALZN |
|---|---|---|
| Price | $4.34 | $1.53 |
| Market cap | $6.3M | $7.4M |
| Today | −4.62% | +4.79% |
| 1 month | −18.1% | +11.7% |
| 6 months | −37.1% | +39.1% |
| Year to date | −17.3% | −15.9% |
| 1 year | — | −39.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $20.0M | $7.6M |
| Dividend yield | — | — |
| Volatility (60d) | 73.9% | 83.1% |
| Short % of float | 0.1% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).